US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

25.57

-0.1000-0.39%

Volume:728.42K

Turnover:18.45M

Market Cap:2.25B

PE:-5.84

High:26.33

Open:25.47

Low:24.98

Close:25.67

52wk High:47.65

52wk Low:22.00

Shares:88.16M

Float Shares:66.03M

Volume Ratio:0.92

T/O Rate:1.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3763

EPS(LYR):-2.2900

ROE:-80.88%

ROA:-46.18%

PB:4.09

PE(LYR):-11.17

Loading ...

Overview Company News Filings

BRIEF-Mineralys Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common Stock

Mineralys to repurchase future royalty payments in Tanabe license agreement

Mineralys Therapeutics prices 5,660,378-share offering at $26.5 per share

Mineralys inks up to $500 million senior secured term loan with Pharmakon Advisors

Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing

THOMSON REUTERS

Mineralys Therapeutics - Secures $500 Mln Senior Secured Term Loan Facility From Pharmakon Advisors

THOMSON REUTERS

Mineralys Therapeutics - Prices $150 Mln Common Stock Offering

THOMSON REUTERS

Mineralys Therapeutics - to Repurchase Lorundrostat Royalty Obligation for $200 Mln Upfront, up to $100 Mln in Milestones

THOMSON REUTERS

Buy Rating Reiterated on MLYS as Launch-HTN Data Highlight Lorundrostat’s Efficacy in Resistant CKD Hypertension; $54 Price Target Unchanged

Mineralys publishes ESH 2026 presentation on lorundrostat in CKD hypertension trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Mineralys Therapeutics presents new data for lorundrostat

BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat

Mineralys Therapeutics Presents New Data From the Phase 3 Launch-Htn Trial of Lorundrostat in Participants With Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

THOMSON REUTERS

Mineralys Therapeutics: Lorundrostat Showed Significant Blood Pressure Reductions in Ckd Patients in Phase 3 Launch-Htn Trial

THOMSON REUTERS

Mineralys Therapeutics: Lorundrostat Significantly Reduced Urine Albumin-to-Creatinine Ratio in Trial

THOMSON REUTERS

Mineralys' pill cuts blood pressure in kidney disease patients

Mineralys Therapeutics: Lorundrostat Demonstrated Favorable Safety Profile in Participants With and Without Chronic Kidney Disease Over 12 Weeks

THOMSON REUTERS

Bayer's Key Pharma Products Face Competitive Risk -- Market Talk

Will Phase 3 Launch-HTN Success and Conference Spotlight Change Mineralys Therapeutics' (MLYS) Narrative?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/MLYS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":25.57,"timestamp":1788292800000,"preClose":25.67,"halted":0,"volume":728423,"delay":0,"changeRate":-0.0038955979742891084,"floatShares":66025800,"shares":88158500,"eps":-4.37633,"marketStatus":"Pre-Mkt","change":-0.1,"latestTime":"09-02 05:11:48 EDT","open":25.47,"high":26.33,"low":24.98,"amount":18445408.377278,"amplitude":0.052591,"askPrice":28.22,"askSize":100,"bidPrice":22.78,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.37633,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":25.57,"postHourTrading":{"tag":"盘后","latestPrice":25.57,"preClose":25.57,"latestTime":"19:30 EDT","volume":17069,"amount":436454.73,"timestamp":1788305406032,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9239005944284454,"impliedVol":0.6003,"impliedVolPercentile":0.0398},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":66025800,"roa":"-46.18%","roe":"-80.88%","lyrEps":-2.29,"volumeRatio":0.9239005944284454,"shares":88158500,"dividePrice":0,"high":26.33,"amplitude":0.052591,"preClose":25.67,"low":24.98,"week52Low":22,"pbRate":"4.09","week52High":47.65,"institutionHeld":0,"latestPrice":25.57,"eps":-4.37633,"divideRate":0,"volume":728423,"delay":0,"ttmEps":-4.37633,"open":25.47,"prevYearClose":36.29,"prevWeekClose":25.6,"prevMonthClose":25.67,"prevQuarterClose":26.98,"fiveDayClose":26.34,"twentyDayClose":26.5,"sixtyDayClose":23.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MLYS","fiscalQuarterEnding":"2026/06","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-2.85},{"market":"US","date":"2026-05-06","symbol":"MLYS","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2026-03-12","symbol":"MLYS","fiscalQuarterEnding":"2025/12","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2025-11-10","symbol":"MLYS","fiscalQuarterEnding":"2025/09","expectedEps":-0.66,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2025-08-12","symbol":"MLYS","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1777348800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2026-08-31","current":-5.842795,"percent":0.637599,"low":-28.120261,"twenty":-16.45829,"median":-9.042924,"eighty":-5.000467,"high":-2.455206,"avg":-10.79434,"sd":5.954931,"marketCap":2263216256},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.982663,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":634011855},{"date":"2024-06-07","current":-7.18498,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":652381815},{"date":"2024-06-14","current":-6.878771,"twenty":-18.699239,"median":-12.004794,"eighty":-7.147798,"marketCap":624578633},{"date":"2024-06-21","current":-6.583498,"twenty":-18.674036,"median":-11.801366,"eighty":-7.108428,"marketCap":597768421},{"date":"2024-06-28","current":-6.397585,"twenty":-18.632904,"median":-11.587276,"eighty":-7.004535,"marketCap":580887918},{"date":"2024-07-05","current":-6.796751,"twenty":-18.599998,"median":-11.08918,"eighty":-6.90283,"marketCap":617131352},{"date":"2024-07-12","current":-7.917695,"twenty":-18.591772,"median":-11.014903,"eighty":-6.90283,"marketCap":718910859},{"date":"2024-07-19","current":-7.217788,"twenty":-18.588966,"median":-10.834579,"eighty":-6.932357,"marketCap":655360728},{"date":"2024-07-26","current":-7.354489,"twenty":-18.580102,"median":-10.505451,"eighty":-6.973914,"marketCap":667772863},{"date":"2024-08-02","current":-6.468669,"twenty":-18.558077,"median":-10.192372,"eighty":-6.88752,"marketCap":587342228},{"date":"2024-08-09","current":-6.025759,"twenty":-18.551128,"median":-10.024815,"eighty":-6.843776,"marketCap":547126910},{"date":"2024-08-16","current":-4.076332,"twenty":-18.496301,"median":-9.845949,"eighty":-6.771136,"marketCap":487818681},{"date":"2024-08-23","current":-4.824282,"twenty":-18.473334,"median":-9.694629,"eighty":-6.684109,"marketCap":577326696},{"date":"2024-08-30","current":-5.156705,"twenty":-18.446961,"median":-9.491619,"eighty":-6.64802,"marketCap":617108036},{"date":"2024-09-06","current":-4.666382,"twenty":-18.432727,"median":-9.462603,"eighty":-6.602089,"marketCap":558430560},{"date":"2024-09-13","current":-4.886612,"twenty":-18.41079,"median":-9.366766,"eighty":-6.532417,"marketCap":584785698},{"date":"2024-09-20","current":-4.865835,"twenty":-18.393266,"median":-9.226167,"eighty":-6.400866,"marketCap":582299364},{"date":"2024-09-27","current":-4.944786,"twenty":-18.318529,"median":-9.18084,"eighty":-6.305758,"marketCap":591747432},{"date":"2024-10-04","current":-5.767531,"twenty":-18.250509,"median":-9.070536,"eighty":-6.252,"marketCap":690206249},{"date":"2024-10-11","current":-5.634562,"twenty":-18.229399,"median":-9.042924,"eighty":-6.143869,"marketCap":674293713},{"date":"2024-10-18","current":-5.983606,"twenty":-18.210635,"median":-8.998552,"eighty":-6.048725,"marketCap":716064120},{"date":"2024-10-25","current":-5.655339,"twenty":-18.194216,"median":-8.973895,"eighty":-5.961361,"marketCap":676780046},{"date":"2024-11-01","current":-5.588854,"twenty":-18.189525,"median":-8.92105,"eighty":-5.849535,"marketCap":668823778},{"date":"2024-11-08","current":-5.834016,"twenty":-18.182489,"median":-8.908316,"eighty":-5.825113,"marketCap":698162517},{"date":"2024-11-15","current":-3.728112,"twenty":-18.13003,"median":-8.863447,"eighty":-5.784153,"marketCap":571344320},{"date":"2024-11-22","current":-4.056108,"twenty":-18.054477,"median":-8.834854,"eighty":-5.738445,"marketCap":621610675},{"date":"2024-11-29","current":-4.147037,"twenty":-18.011266,"median":-8.824542,"eighty":-5.694398,"marketCap":635545903},{"date":"2024-12-06","current":-4.289927,"twenty":-17.971392,"median":-8.704678,"eighty":-5.652845,"marketCap":657444117},{"date":"2024-12-13","current":-3.864506,"twenty":-17.93941,"median":-8.597282,"eighty":-5.622096,"marketCap":592247161},{"date":"2024-12-20","current":-4.007395,"twenty":-17.918728,"median":-8.45617,"eighty":-5.566415,"marketCap":614145375},{"date":"2024-12-27","current":-4.163275,"twenty":-17.89399,"median":-8.38318,"eighty":-5.386048,"marketCap":638034336},{"date":"2025-01-03","current":-4.140542,"twenty":-17.884608,"median":-8.283595,"eighty":-5.230583,"marketCap":634550529},{"date":"2025-01-10","current":-3.205267,"twenty":-17.865843,"median":-8.193856,"eighty":-5.186749,"marketCap":491216763},{"date":"2025-01-17","current":-3.000675,"twenty":-17.75795,"median":-8.130978,"eighty":-5.093743,"marketCap":459862501},{"date":"2025-01-24","current":-3.237742,"twenty":-17.725112,"median":-7.972375,"eighty":-5.030384,"marketCap":496193629},{"date":"2025-01-31","current":-3.344909,"twenty":-17.66738,"median":-7.925786,"eighty":-4.98717,"marketCap":512617290},{"date":"2025-02-07","current":-3.185782,"twenty":-17.600622,"median":-7.886161,"eighty":-4.961636,"marketCap":488230642},{"date":"2025-02-14","current":-2.870012,"twenty":-17.57969,"median":-7.841803,"eighty":-4.929578,"marketCap":510316922},{"date":"2025-02-21","current":-2.679426,"twenty":-17.570308,"median":-7.800135,"eighty":-4.913205,"marketCap":476428689},{"date":"2025-02-28","current":-2.56171,"twenty":-17.532779,"median":-7.76156,"eighty":-4.879413,"marketCap":455497722},{"date":"2025-03-07","current":-2.948489,"twenty":-17.497596,"median":-7.666927,"eighty":-4.847705,"marketCap":524270901},{"date":"2025-03-14","current":-5.032788,"twenty":-17.464759,"median":-7.556805,"eighty":-4.833314,"marketCap":894880035},{"date":"2025-03-21","current":-6.142597,"twenty":-17.410812,"median":-7.474785,"eighty":-4.837364,"marketCap":1092215135},{"date":"2025-03-28","current":-5.337906,"twenty":-17.394393,"median":-7.420413,"eighty":-4.839437,"marketCap":949133010},{"date":"2025-04-04","current":-4.515009,"twenty":-17.356865,"median":-7.381829,"eighty":-4.839437,"marketCap":802813733},{"date":"2025-04-11","current":-4.88916,"twenty":-17.298227,"median":-7.359957,"eighty":-4.826979,"marketCap":869341455},{"date":"2025-04-17","current":-4.870916,"twenty":-17.237243,"median":-7.346287,"eighty":-4.83217,"marketCap":866097643},{"date":"2025-04-25","current":-4.867268,"twenty":-17.117621,"median":-7.217788,"eighty":-4.83083,"marketCap":865448881},{"date":"2025-05-02","current":-5.626182,"twenty":-17.049602,"median":-7.174044,"eighty":-4.83217,"marketCap":1000391435},{"date":"2025-05-09","current":-5.345238,"twenty":-17.026147,"median":-7.146704,"eighty":-4.837056,"marketCap":950436740},{"date":"2025-05-16","current":-5.307011,"twenty":-16.932326,"median":-7.108428,"eighty":-4.838863,"marketCap":1000440655},{"date":"2025-05-23","current":-5.642373,"twenty":-16.739993,"median":-7.070152,"eighty":-4.844431,"marketCap":1063660683},{"date":"2025-05-30","current":-5.414189,"twenty":-16.571115,"median":-7.048279,"eighty":-4.857525,"marketCap":1020644994},{"date":"2025-06-06","current":-5.40036,"twenty":-16.559387,"median":-6.993599,"eighty":-4.86168,"marketCap":1018037982},{"date":"2025-06-13","current":-5.158346,"twenty":-16.512477,"median":-6.906111,"eighty":-4.865835,"marketCap":972415282},{"date":"2025-06-20","current":-4.746923,"twenty":-16.418656,"median":-6.878771,"eighty":-4.854252,"marketCap":894856690},{"date":"2025-06-27","current":-4.840271,"twenty":-16.273234,"median":-6.854165,"eighty":-4.839875,"marketCap":912454018},{"date":"2025-07-03","current":-5.026967,"twenty":-16.102011,"median":-6.815889,"eighty":-4.834459,"marketCap":947648672},{"date":"2025-07-11","current":-5.061541,"twenty":-16.001153,"median":-6.774878,"eighty":-4.830927,"marketCap":954166201},{"date":"2025-07-18","current":-4.95782,"twenty":-15.757219,"median":-6.718225,"eighty":-4.834459,"marketCap":934613615},{"date":"2025-07-25","current":-4.930162,"twenty":-14.706714,"median":-6.670986,"eighty":-4.828181,"marketCap":929399592},{"date":"2025-08-01","current":-4.892131,"twenty":-14.028818,"median":-6.651848,"eighty":-4.823763,"marketCap":922230311},{"date":"2025-08-08","current":-4.449592,"twenty":-13.915218,"median":-6.625405,"eighty":-4.809096,"marketCap":838805943},{"date":"2025-08-15","current":-4.827344,"twenty":-13.761419,"median":-6.586232,"eighty":-4.762827,"marketCap":920926805},{"date":"2025-08-22","current":-5.077095,"twenty":-13.590144,"median":-6.552758,"eighty":-4.766426,"marketCap":968572638},{"date":"2025-08-29","current":-5.289075,"twenty":-13.503535,"median":-6.457733,"eighty":-4.786431,"marketCap":1009012700},{"date":"2025-09-05","current":-13.211526,"twenty":-13.468581,"median":-6.485287,"eighty":-4.805659,"marketCap":2520402357},{"date":"2025-09-12","current":-15.109527,"twenty":-13.879712,"median":-6.581817,"eighty":-4.817518,"marketCap":2882489791},{"date":"2025-09-19","current":-16.211433,"twenty":-14.67771,"median":-6.599902,"eighty":-4.819952,"marketCap":3092703659},{"date":"2025-09-26","current":-15.658447,"twenty":-15.194101,"median":-6.643646,"eighty":-4.82127,"marketCap":2987208877},{"date":"2025-10-03","current":-16.451331,"twenty":-15.631718,"median":-6.654582,"eighty":-4.823503,"marketCap":3138469778},{"date":"2025-10-10","current":-16.016261,"twenty":-15.631718,"median":-6.68739,"eighty":-4.825507,"marketCap":3055470207},{"date":"2025-10-17","current":-17.471915,"twenty":-15.790187,"median":-6.743652,"eighty":-4.828719,"marketCap":3333169708},{"date":"2025-10-24","current":-16.593644,"twenty":-16.004913,"median":-6.791282,"eighty":-4.830879,"marketCap":3165619171},{"date":"2025-10-31","current":-16.719692,"twenty":-16.218752,"median":-6.840495,"eighty":-4.833314,"marketCap":3189665776},{"date":"2025-11-07","current":-15.048536,"twenty":-16.218752,"median":-6.86514,"eighty":-4.837364,"marketCap":2870854337},{"date":"2025-11-14","current":-20.454291,"twenty":-16.296821,"median":-6.897909,"eighty":-4.839082,"marketCap":3505108651},{"date":"2025-11-21","current":-19.336671,"twenty":-16.504283,"median":-6.982663,"eighty":-4.840626,"marketCap":3313589957},{"date":"2025-11-28","current":-19.913954,"twenty":-16.568769,"median":-7.015471,"eighty":-4.844431,"marketCap":3412514902},{"date":"2025-12-05","current":-17.969665,"twenty":-16.769708,"median":-7.064684,"eighty":-4.858356,"marketCap":3079335687},{"date":"2025-12-12","current":-16.648841,"twenty":-16.96846,"median":-7.108428,"eighty":-4.862511,"marketCap":2852995413},{"date":"2025-12-19","current":-17.087577,"twenty":-17.041159,"median":-7.14397,"eighty":-4.866122,"marketCap":2928178372},{"date":"2025-12-26","current":-17.286162,"twenty":-17.087577,"median":-7.15764,"eighty":-4.867268,"marketCap":2962208553},{"date":"2026-01-02","current":-16.75968,"twenty":-17.088816,"median":-7.187714,"eighty":-4.870186,"marketCap":2871989003},{"date":"2026-01-09","current":-15.300308,"twenty":-17.059073,"median":-7.271963,"eighty":-4.873874,"marketCap":2621906742},{"date":"2026-01-16","current":-14.492112,"twenty":-17.043505,"median":-7.354489,"eighty":-4.884212,"marketCap":2483411819},{"date":"2026-01-23","current":-15.831409,"twenty":-17.04069,"median":-7.370893,"eighty":-4.887849,"marketCap":2712917691},{"date":"2026-01-30","current":-14.820009,"twenty":-17.021528,"median":-7.392765,"eighty":-4.888966,"marketCap":2539601188},{"date":"2026-02-06","current":-13.028123,"twenty":-17.009066,"median":-7.434083,"eighty":-4.890943,"marketCap":2232538158},{"date":"2026-02-13","current":-12.866483,"twenty":-16.985539,"median":-7.48264,"eighty":-4.894697,"marketCap":2204839174},{"date":"2026-02-20","current":-12.958849,"twenty":-16.967066,"median":-7.595082,"eighty":-4.899313,"marketCap":2220667165},{"date":"2026-02-27","current":-13.40682,"twenty":-16.890615,"median":-7.678432,"eighty":-4.90682,"marketCap":2297432922},{"date":"2026-03-06","current":-12.340001,"twenty":-16.773199,"median":-7.793482,"eighty":-4.913205,"marketCap":2114619624},{"date":"2026-03-13","current":-12.464694,"twenty":-16.743685,"median":-7.809191,"eighty":-4.917335,"marketCap":2135987412},{"date":"2026-03-20","current":-12.403799,"twenty":-16.719061,"median":-7.868689,"eighty":-4.919816,"marketCap":1918259847},{"date":"2026-03-27","current":-12.579626,"twenty":-16.690405,"median":-7.90391,"eighty":-4.921211,"marketCap":1945451675},{"date":"2026-04-02","current":-14.071491,"twenty":-16.647917,"median":-7.936683,"eighty":-4.923691,"marketCap":2176170213},{"date":"2026-04-10","current":-14.476426,"twenty":-16.642376,"median":-7.972375,"eighty":-4.925502,"marketCap":2238793817},{"date":"2026-04-17","current":-16.293018,"twenty":-16.630784,"median":-8.156199,"eighty":-4.925808,"marketCap":2519731592},{"date":"2026-04-24","current":-15.189401,"twenty":-16.609908,"median":-8.221771,"eighty":-4.927198,"marketCap":2349056055},{"date":"2026-05-01","current":-14.208408,"twenty":-16.589138,"median":-8.357548,"eighty":-4.930594,"marketCap":2197344467},{"date":"2026-05-08","current":-15.944002,"twenty":-16.568769,"median":-8.45617,"eighty":-4.933174,"marketCap":2419964732},{"date":"2026-05-15","current":-14.822362,"twenty":-16.554853,"median":-8.597282,"eighty":-4.937273,"marketCap":2249723214},{"date":"2026-05-22","current":-16.431243,"twenty":-16.531871,"median":-8.704678,"eighty":-4.940953,"marketCap":2493917593},{"date":"2026-05-29","current":-17.143281,"twenty":-16.536719,"median":-8.822029,"eighty":-4.944786,"marketCap":2601990105},{"date":"2026-06-05","current":-13.615701,"twenty":-16.559387,"median":-8.834854,"eighty":-4.947538,"marketCap":2066577430},{"date":"2026-06-12","current":-13.01237,"twenty":-16.536719,"median":-8.863447,"eighty":-4.950906,"marketCap":1975004537},{"date":"2026-06-18","current":-13.659184,"twenty":-16.517325,"median":-8.904865,"eighty":-4.950906,"marketCap":2073177278},{"date":"2026-06-26","current":-14.316868,"twenty":-16.496089,"median":-8.91986,"eighty":-4.950906,"marketCap":2172999980},{"date":"2026-07-02","current":-15.61864,"twenty":-16.491889,"median":-8.953186,"eighty":-4.955054,"marketCap":2370581500},{"date":"2026-07-10","current":-16.820967,"twenty":-16.545786,"median":-8.994603,"eighty":-4.959972,"marketCap":2553069551},{"date":"2026-07-17","current":-15.728998,"twenty":-16.522174,"median":-9.036021,"eighty":-4.961636,"marketCap":2387331611},{"date":"2026-07-24","current":-15.682531,"twenty":-16.500186,"median":-9.059079,"eighty":-4.964053,"marketCap":2380278933},{"date":"2026-07-31","current":-15.212055,"twenty":-16.491923,"median":-9.139785,"eighty":-4.966614,"marketCap":2308870565},{"date":"2026-08-07","current":-15.676723,"twenty":-16.49182,"median":-9.209355,"eighty":-4.972127,"marketCap":2379397348},{"date":"2026-08-14","current":-6.598095,"twenty":-16.488725,"median":-9.208309,"eighty":-4.97969,"marketCap":2306535629},{"date":"2026-08-21","current":-6.51211,"twenty":-16.477941,"median":-9.105161,"eighty":-4.985507,"marketCap":2276477288},{"date":"2026-08-28","current":-6.577863,"twenty":-16.46177,"median":-9.049827,"eighty":-4.997142,"marketCap":2299463078},{"date":"2026-08-31","current":-6.474175,"twenty":-16.45829,"median":-9.042924,"eighty":-5.000467,"marketCap":2263216256}],"updateTime":1788328026990},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640905384","title":"BRIEF-Mineralys Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2640905384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640905384?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:27","pubTimestamp":1780482470,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Announces Pricing Of $150 Million Underwritten Offering Of Common StockJune 3 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS ANNOUNCES PRICING OF $15","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1XZ9NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640890306","title":"Mineralys to repurchase future royalty payments in Tanabe license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640890306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640890306?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:19","pubTimestamp":1780481993,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) announced the repurchase of all potential future royalty payments due to Tanabe Pharma Corporation related to lorundr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-to-repurchase-future-royalty-payments-in-tanabe-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-to-repurchase-future-royalty-payments-in-tanabe-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640039189","title":"Mineralys Therapeutics prices 5,660,378-share offering at $26.5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640039189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640039189?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:05","pubTimestamp":1780481113,"startTime":"0","endTime":"0","summary":"Mineralys priced an underwritten follow-on offering of 5,660,378 common shares at USD 26.5 each.Gross proceeds expected at about USD 150 million; closing expected on or about June 4, 2026.Net proceeds earmarked to help fund a USD 200 million upfront payment to repurchase a royalty obligation tied to Tanabe Pharma.BofA Securities, Goldman Sachs, Evercore ISI named joint book-running managers.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL2D2R53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443978.SGD","LU0170899867.USD","LU0321505439.SGD","BK4112","IE00BLSP4239.USD","LU0648001328.SGD","LU1366192091.USD","LU0321505868.SGD","LU1791807156.HKD","LU0251142724.SGD","LU1868837136.USD","LU0942090050.USD","BK4127","LU0098860793.USD","LU0106831901.USD","BK4207","LU0345770308.USD","LU0234572021.USD","LU1267930227.SGD","LU1883839398.USD","LU0149725797.USD","IE00B19Z3B42.SGD","LU0314106906.USD","LU0648000940.SGD","LU1894683348.USD","BK4553","NDAQ","LU1280957306.USD","LU1668664300.SGD","LU1868836591.USD","BAC","LU1506573853.SGD","EVR","LU1880398554.USD","LU1496350502.SGD","IE0004091025.USD","LU0868494708.USD","LU1201861249.SGD","LU2237443549.SGD","IE00BBT3K403.USD","LU1496350171.SGD","LU0211331839.USD","GSX","IE00BN0W2V16.EUR","BK4139","MLYS","LU1868837300.USD","IE00BKVL7J92.USD","LU0061475181.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903514","title":"Mineralys inks up to $500 million senior secured term loan with Pharmakon Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903514?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:01","pubTimestamp":1780480865,"startTime":"0","endTime":"0","summary":"Mineralys entered an up to USD 500 million senior secured term loan facility with funds managed by Pharmakon Advisors.USD 100 million will fund at closing; remaining capacity available in four tranches subject to customary drawdown conditions.Five-year term matures in June 2031; interest set at SOFR with a 3.25% floor, plus a 5.5% margin.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL47w4q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","LU0314104364.USD","LU2095319765.USD","BK4139","BK4585","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","SG9999014013.SGD","IE00BN0W2T93.GBP","MLYS","SG9999014039.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903889","title":"Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903889","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903889?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640326903","title":"Mineralys Therapeutics - Secures $500 Mln Senior Secured Term Loan Facility From Pharmakon Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640326903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640326903?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640033479","title":"Mineralys Therapeutics - Prices $150 Mln Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640033479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640033479?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640033239","title":"Mineralys Therapeutics - to Repurchase Lorundrostat Royalty Obligation for $200 Mln Upfront, up to $100 Mln in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2640033239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640033239?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:00","pubTimestamp":1780480800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA2JCGKB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640690049","title":"Buy Rating Reiterated on MLYS as Launch-HTN Data Highlight Lorundrostat’s Efficacy in Resistant CKD Hypertension; $54 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690049","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640690049?lang=en_us&edition=fundamental","pubTime":"2026-06-02 02:45","pubTimestamp":1780339524,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Mineralys Therapeutics, Inc., with a price target of $54....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-mlys-as-launch-htn-data-highlight-lorundrostats-efficacy-in-resistant-ckd-hypertension-54-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-mlys-as-launch-htn-data-highlight-lorundrostats-efficacy-in-resistant-ckd-hypertension-54-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640501199","title":"Mineralys publishes ESH 2026 presentation on lorundrostat in CKD hypertension trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640501199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640501199?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:35","pubTimestamp":1780324510,"startTime":"0","endTime":"0","summary":"Mineralys published an ESH 2026 presentation on lorundrostat for hypertension in chronic kidney disease, reporting results from the LAUNCH-HTN trial.Primary endpoint: ambulatory office systolic blood pressure fell 16.9 mmHg at 6 weeks on lorundrostat 50 mg; placebo-adjusted decline was 9.1 mmHg.Predefined 12-week endpoint: ambulatory office systolic blood pressure fell 19.0 mmHg; placebo-adjusted decline was 11.6 mmHg.CKD subgroup analysis included 192 participants with baseline eGFR under 60 mL/min/1.73m or UACR at least 30 mg/g, out of 800 with baseline renal data.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief on May 30, 2026, and is solely r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL3LP8vt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640953797","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640953797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640953797?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:40","pubTimestamp":1780310417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS), Iovance Biother...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-196?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-196?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986644","title":"Mineralys Therapeutics presents new data for lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986644","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986644?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:05","pubTimestamp":1780261504,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) presented new clinical data for lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protecti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-presents-new-data-for-lorundrostat-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-presents-new-data-for-lorundrostat-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS","EPV","LENZ","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360972","title":"BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360972","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639360972?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154139,"startTime":"0","endTime":"0","summary":"BRIEF-Mineralys Therapeutics Presents New Data From The Phase 3 Launch-Htn Trial Of Lorundrostat May 30 (Reuters) - Mineralys Therapeutics Inc MLYS.O:MINERALYS THERAPEUTICS PRESENTS NEW DATA FROM THE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA7YXNFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639717609","title":"Mineralys Therapeutics Presents New Data From the Phase 3 Launch-Htn Trial of Lorundrostat in Participants With Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639717609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639717609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nTUA7YXNFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609748","title":"Mineralys Therapeutics: Lorundrostat Showed Significant Blood Pressure Reductions in Ckd Patients in Phase 3 Launch-Htn Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609748?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639609712","title":"Mineralys Therapeutics: Lorundrostat Significantly Reduced Urine Albumin-to-Creatinine Ratio in Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609712?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639560974","title":"Mineralys' pill cuts blood pressure in kidney disease patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2639560974","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639560974?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":"Mineralys' pill cuts blood pressure in kidney disease patients  May 30 (Reuters) - Mineralys Therapeutics' MLYS.O experimental drug significantly reduced blood pressure in patients with chronic kidney","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nL4N4251J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046234339.USD","LU0640478417.SGD","LU2112291526.USD","LU0738911758.USD","LU1019632923.USD","LU2324357040.USD","LU2237443549.SGD","LU0432979614.USD","LU1261432733.SGD","LU0784384876.USD","LU0661504455.SGD","LU1267930813.SGD","LU0052756011.USD","IE0002141913.USD","LU0114720955.EUR","LU0857590862.USD","LU0289739699.SGD","IE00B2B36J28.USD","MLYS","LU0969580561.USD","LU0553294199.USD","LU1355424745.HKD","LU1051770623.HKD","LU1481600234.SGD","LU0859254822.USD","LU0920840948.USD","LU0976567544.SGD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU2433249047.HKD","LU0997586432.USD","LU1153585028.USD","LU0128525689.USD","LU1267930227.SGD","LU2468319806.SGD","LU1153584641.USD","AZN.UK","LU1273509221.SGD","IE00BFTCPJ56.SGD","IE00B3T34201.USD","LU0997586515.USD","03165","LU1003076772.USD","LU1023059063.AUD","LU0266013472.USD","LU2539964713.USD","LU2125909247.SGD","LU0557290698.USD","LU2355687059.USD","LU0960981461.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639060971","title":"Mineralys Therapeutics: Lorundrostat Demonstrated Favorable Safety Profile in Participants With and Without Chronic Kidney Disease Over 12 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2639060971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639060971?lang=en_us&edition=fundamental","pubTime":"2026-05-30 23:15","pubTimestamp":1780154100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nP8N3Z60BO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639986640","title":"Bayer's Key Pharma Products Face Competitive Risk -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2639986640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639986640?lang=en_us&edition=fundamental","pubTime":"2026-05-29 16:15","pubTimestamp":1780042500,"startTime":"0","endTime":"0","summary":"0815 GMT - Bayer's pharmaceutical business has good momentum but faces risks over the medium term from potential competition to key products like its Kerendia kidney drug and asundexian for stroke prevention, Jefferies analysts say. The German group's pharma division should deliver annual sales growth of 2% over the 2025-2030 period, compared with the average growth rate of 5% among peers, according to Jefferies. Asundexian's potential market is a lot smaller after a trial for a type of heart arrhythmia known as atrial fibrillation failed and Bristol Myers Squibb's rival treatment milvexian could have an edge, they add. For Bayer's Kerendia, momentum is good for now, but the threat of competition looms on the horizon with AstraZeneca and Mineralys Therapeutics developing a new class of drugs, Jefferies says. Bayer shares fall 1.3%. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1718418525.SGD","LU0432979614.USD","LU0889565916.HKD","LU0225284248.USD","LU0225771236.USD","IE0009355771.USD","BK4568","LU1074936037.SGD","LU2237443382.USD","LU1585245621.USD","BAYRY","LU2125154778.USD","AZN","LU1829250122.USD","LU2242646821.SGD","LU1989771016.USD","LU1670710588.SGD","IE0002141913.USD","MLYS","LU1430594728.SGD","LU0456855351.SGD","LU2237443895.HKD","IE00BJJMRZ35.SGD","BK4139","LU1670710661.SGD","IE00BJT1NW94.SGD","IE00BFXG1179.USD","LU1323610961.USD","LU1670711123.USD","LU2462157665.USD","BMY","LU2456880835.USD","LU1868836757.USD","LU0321505868.SGD","LU2360032135.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU0061475181.USD","LU1291159041.SGD","LU1868837300.USD","LU2242652126.USD","LU0882574055.USD","LU2237443622.USD","LU0058720904.USD","AZNH","LU2125154935.USD","LU0306806265.USD","LU0289739699.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639496716","title":"Will Phase 3 Launch-HTN Success and Conference Spotlight Change Mineralys Therapeutics' (MLYS) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2639496716","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639496716?lang=en_us&edition=fundamental","pubTime":"2026-05-29 12:33","pubTimestamp":1780029238,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics recently highlighted that positive Phase 3 Launch-HTN data for lorundrostat in uncontrolled hypertension and chronic kidney disease were featured in an oral presentation at the European Meeting on Hypertension and Cardiovascular Protection 2026, following completion of six late-stage trials supporting its efficacy and safety profile.\nThe company also confirmed participation in the Jefferies 2026 Global Healthcare Conference, underscoring growing clinical and investor...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/will-phase-3-launch-htn-success-and-conference-spotlight-cha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/will-phase-3-launch-htn-success-and-conference-spotlight-cha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":109,"code":"91000000","status":"200"}]}}